Patients with CRC exhibited reduced activity of the protein encoded by the MAP2K4 gene compared to healthy individuals; moreover, this loss of activity correlated with the occurrence of cancer metastases to lymph nodes and distant organs and with the clinical stage of the primary cancer. This evidence concerns the gene MAP2K4 and cancer.